BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2002
View Archived Issues
DB-289 enters phase II trial for PCP in HIV/AIDS patients
Read More
Third phase III trial under way for INS-365 Ophthalmic in dry eye
Read More
Promising profile reported at AACR meeting for novel histone deacetylase inhibitor CG-1521
Read More
LAQ-824: a potential new antitumor agent acting via inhibition of histone deacetylase
Read More
Novel RXR agonist characterized at ACS meeting by GSK
Read More
Flt-3 kinase inhibitors and potential for treatment of AML discussed in Orlando by Millennium
Read More
Favorable pharmacokinetic profile seen for novel tyrosine kinase inhibitor CHIR-200131
Read More
Orally active VEGF receptor tyrosine kinase-selective agent presented at AACR meeting
Read More
Independent review and long-term follow-up of phase II Orathecin study
Read More
ACS news: Abbott describes discovery of new series of PTP1B inhibitors
Read More
Potent, selective, nonpeptide PTP1B inhibitors discovered in Novo Nordisk/Ontogen joint effort
Read More
Adherex and AstraZeneca extend Exherin collaboration agreement
Read More
European Commission designates E21R orphan drug in JMML
Read More
IAVI-sponsored AIDS vaccines enter phase II
Read More
Gliatech receives grant for selective GlyT1 inhibitor development
Read More
Collateral updates achievements of 2001
Read More
Preclinical data discussed this week support clinical trials with thioplatin
Read More
WX-G250 and WX-G250RIT designated orphan drugs for renal cell carcinoma in E.U.
Read More
Inhibitors of uPA with favorable PK properties described in patent literature
Read More
New vascular damaging agents in development at Angiogene Pharmaceuticals
Read More
Neurogen patents new series for CNS disorders
Read More
Potent and selective uPA inhibitors designed by Corvas scientists
Read More
Streptomyces strain discovered to produce new antitumor compounds
Read More
Antiherpesvirus agents jointly prepared by Pfizer and JT
Read More
Japan Tobacco patents analgesic thiazole compounds
Read More
Gene-based therapy EG-009 designated orphan drug for high-grade glioma
Read More
FDA approves SecreFlo for diagnosis of pancreatic dysfunction
Read More